These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8279038)

  • 1. Active cytomegalovirus infection in hemodialysis patients receiving donor-specific blood transfusions under azathioprine coverage.
    Suassuna JH; Machado RD; Sampaio JC; Leite LL; Villela LH; Ruzany F; Souza ER; Moraes JR
    Transplantation; 1993 Dec; 56(6):1552-4. PubMed ID: 8279038
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors contributing to the risk of cytomegalovirus infection in patients receiving renal transplants.
    Ho M; Dowling JN; Armstrong JA; Suwansirikul S; Wu B; Youngblood LA; Saslow A
    Yale J Biol Med; 1976 Mar; 49(1):17-26. PubMed ID: 183377
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus infection in renal transplant patients.
    Cardella CJ; Vas S; Young E; Harding M
    Transplant Proc; 1985 Aug; 17(4):1959-60. PubMed ID: 2992132
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of ganciclovir prophylaxis on cytomegalovirus infection in cadaveric kidney vs combined kidney and pancreas transplantation.
    Peddi VR; Hariharan S; Munda R; Schroeder TJ; First MR
    Transplant Proc; 1995 Dec; 27(6):3076-7. PubMed ID: 8539851
    [No Abstract]   [Full Text] [Related]  

  • 5. The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney.
    Grundy JE; Super M; Lui S; Sweny P; Griffiths PD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2126-8. PubMed ID: 2856275
    [No Abstract]   [Full Text] [Related]  

  • 6. [Seroprevalence of cytomegalovirus infections in patients on hemodialysis, renal allograft recipients and the general population of French-speaking Switzerland].
    Lopez-Mata P; Lavanchy D; Wauters JP; Frei PC
    Rev Med Suisse Romande; 1992 May; 112(5):459-63. PubMed ID: 1318567
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study.
    Moreno de la Higuera Díaz MA; Calvo Romero N; Sánchez-Fructuoso A; Conesa J; Marques Vidas M; Prats D; Barrientos Guzmán A
    Transplant Proc; 2007 Sep; 39(7):2231-2. PubMed ID: 17889147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymerase chain reaction in diagnosis of cytomegalovirus infection in patients with organ allotransplants].
    Vediakov AM; Dolgikh MS
    Ter Arkh; 1998; 70(4):45-8. PubMed ID: 9612903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus infection in recipients of living unrelated donor renal transplants--a report of 4 cases.
    Hooi LS
    Med J Malaysia; 1993 Jun; 48(2):232-5. PubMed ID: 8350803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus prophylaxis in antibody-treated renal transplanted patients.
    Birkeland S; Gahrn-Hansen B; Andersen H; Rohr N; Larsen KE; Jørgensen A
    Transplant Proc; 1995 Dec; 27(6):3473-6. PubMed ID: 8540056
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus infection acquired through blood transfusions.
    Rekha S; Chandrasekhara MK; Yeshwanth M
    Indian Pediatr; 1995 May; 32(5):575-7. PubMed ID: 8613317
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis and liver damage among patients and staff in a transplantation unit.
    Franksson C
    Transplant Proc; 1969 Mar; 1(1):209-12. PubMed ID: 4944220
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cytomegalovirus infection and its prevention after autologous bone marrow transplantation.
    Verdonck LF; Middeldorp JM; Kreeft HA; The TH; Hekker A; de Gast GC
    Transplantation; 1985 Apr; 39(4):455-7. PubMed ID: 2984811
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence of transfusion transmitted diseases in renal transplant recipients.
    Choudhury N; Naik S; Sharma RK; Elhence P; Ramesh V; Gupta RK
    Indian J Pathol Microbiol; 1996 Jul; 39(3):191-5. PubMed ID: 8972147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CARI guidelines. CMV disease and kidney transplant: prophylaxis for cytomegalovirus infection in patients following renal transplantation.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S27-31. PubMed ID: 15469551
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinfection or reactivation of cytomegalovirus infection in renal transplantation.
    Lauzurica R; Borràs M; Serra A; Teixidó J; Bonal J; Bonet J; Torguet P; Romero R; Caralps A
    Transplant Proc; 1992 Feb; 24(1):85-6. PubMed ID: 1311482
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytomegalovirus infection after kidney transplantation--importance of the primary infection].
    Castro LA; Schleibner S; Hillebrand G; Land W
    Immun Infekt; 1985 Sep; 13(5):210-4. PubMed ID: 2998976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.